EFFECT OF BROMOCRIPTINE TREATMENT ON LEFT AND RIGHT VENTRICULAR FUNCTION IN PERIPARTUM CARDIOMYOPATHY
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31365-6
Abstract: Peripartum cardiomyopathy (PPCM) is a rare but devastating cause of heart failure in peripartum women. At the time of diagnosis, approximately one-third of patients exhibit right ventricular (RV) dysfunction on echocardiography. Improvement in RV function… read more here.
Keywords: effect bromocriptine; right ventricular; bromocriptine treatment; peripartum cardiomyopathy ... See more keywords
Sexual Functioning in Hyperprolactinemic Patients Treated With Cabergoline or Bromocriptine.
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000777
Abstract: BACKGROUND Elevated prolactin levels were found to be associated with impaired sexuality. STUDY QUESTION The aim of the study was to compare the impact of bromocriptine and cabergoline on sexual functioning in both genders. STUDY… read more here.
Keywords: prolactin levels; sexual functioning; bromocriptine treatment; study ... See more keywords
Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1026168
Abstract: Objective Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of… read more here.
Keywords: proliferation; bromocriptine treatment; women adenomyosis; endometrium women ... See more keywords